openPR Logo
Press release

Liposome Drug Delivery Market - Current Scenario and Future Growth Analysis 2017 - 2025

04-10-2018 10:29 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Liposome Drug Delivery Market - Current Scenario and Future

Liposomes are small spherical-shaped artificial vesicles synthesized from phospholipids and cholesterol. They are colloidal carriers and range from 0.01 to 5.0 μm in diameter. These are lipid bilayer vesicles having hydrophilic and hydrophobic properties. Due to these properties liposomes have an advantage of encapsulating hydrophobic as well as hydrophilic drugs and delivering them to the targeted site in the body. Thus, liposomes are promising systems for targeted drug delivery.  Liposomes are successfully used for encapsulating various drug molecules such as acyclovir, tropicamaide, chloroquine diphosphate, paclitaxel, and cyclosporine. Many therapeutic agents such as antimicrobials, anticancer drugs, genetic materials, vaccines, macromolecules, and proteins can be encapsulated in liposomes. Liposomes are employed as drug carriers for targeted drug therapy for various diseases, as they are biocompatible and biodegradable. 

Download PDF Brochure of Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28571

The classification of liposomes is based on its structural properties or on the method of preparation used. Structurally, liposomes are classified into the following groups: multilamellar large vesicles (MLV), oligolamellar vesicles (OLV), unilamellar vesicles (UV), small unilamellar vesicles (SUV), medium-sized unilamellar vesicles (MUV), large unilamellar vesicles (LUV), giant unilamellar vesicles (GUV), and multivesicular vesicles (MVV). In terms of preparation method used, liposomes can be classified into the following types: reverse phase evaporation method for single or oligolamellar vescile (REV), multilamellar vesicles (MLV) made by reverse phase evaporation method, stable plurilamellar vesicles, (FATMLV) frozen and thawed, vesicles prepared by extrusion method (VET), vesicles prepared by fusion (FUV), vesicles prepared by french press (FPV), dehydration?rehydration vesicles (DRV), and bubblesomes (BSV).

Development in scientific research in recent years has led to the rapid expansion of the global liposome drug delivery market. Increased understanding of targeted drug delivery system has fuelled the liposome drug delivery system market. Advantages such as improvement and control over pharmacokinetics and pharmacodynamics, decreased toxicity, and enhanced activity of drugs against intracellular pathogens are key divers for pharmaceutical companies to invest in the global liposomes drug delivery market. Currently, there are a number of liposomal products such as ambisome, myocet, doxil, depoCyt, etc., approved by the FDA for commercial usage. However, low solubility, short half-life and high production cost are key restraints of the global liposome drug delivery market.

Request to View TOC of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=28571

In terms of type of industry, the liposome drug delivery market can be segmented into pharmaceutical, cosmetic, food, and farming. The pharmaceutical industry segment led the global liposomes market due to rapid advancements in targeted drug delivery systems. In terms of product, the market can be segmented into liposomal doxorubicin, liposomal amphoteracin B, and liposomal paclitaxel. Liposomal amphoteracin B is used in the treatment of various fungal and parasitic infections. In terms of application, the global liposomes drug delivery market can be segmented into therapeutic and clinical. Therapeutic applications include occular and pulmonary applications, whereas clinical applications consists of cancer (antitumor) therapy and fungal and microbial infection therapy. Ongoing research and advancement in liposome design are leading to new applications for the delivery of new biotechnology products such as recombinant proteins antisense oligonucleotides and cloned genes.

Request to View Discount –

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=28571

In terms of geography, the global liposomes drug delivery market can be segmented into North America (Canada, the U.S., and Mexico), Europe (Germany, France, the U.K., Russia, and Italy), Asia Pacific (Japan, China, Korea, India, and Southeast Asia), Latin America, and Middle East & Africa. North America is a leading market for liposomes drug delivery systems due to increase in novel technologies in targeted drug delivery systems. The market is anticipated to expand during the forecast period in other parts of the globe as well.

Prominent manufacturers operating in the global liposome drug delivery market include Johnson & Johnson, Sun Pharmaceutical, Teva Pharmaceutical Industries Ltd., Novartis AG, Gilead Sciences, Inc., Kingond Pharm, and Celsion Corporation.

More Trending Reports by Transparency Market Research:

High-flow Nasal Cannula Market

https://www.prnewswire.com/news-releases/high-flow-nasal-cannula-market-worth-us-908-billion-by-2025-globally-transparency-market-research-650601433.html

Medical Imaging Information System Market

https://www.prnewswire.com/news-releases/global-medical-imaging-information-system-market-players-focusing-on-product-advancements-for-business-expansion-observes-tmr-650084663.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liposome Drug Delivery Market - Current Scenario and Future Growth Analysis 2017 - 2025 here

News-ID: 1009164 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Liposomes

Digitized overhaul to drive the Liposomes Market
The Liposomes Market is expected to grow on a healthy note further. The current scenario is such that virtual monitoring tools are being called for. They act as a precision factor for the healthcare vertical. With the turning out to be more accessible for patients and providers alike, several post-operative intervention options are being made available for preventing hospital re-admittance and complications. With cost-effectiveness rendered as well, the healthcare vertical
The Liposomes Market to Stick To Digitized Innovation
The Liposomes Market is bound to witness stupendous growth going forward. With advancements in technology, healthcare organizations are into the development of a holistic strategy for building awareness regarding advanced healthcare infrastructure. eBooks and blog posts are also being used to increase the benevolence amongst patients. The healthcare vertical is expected to move in this direction shortly. Liposomes are a novel system widely used in the field of drug delivery, gene
Liposomes Market Registering a Strong Growth by 2025
Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer. Liposomes can be divided into two categories on the basis of their size and the number of bilayers – unilamellar vesicles and multilamellar vesicles. Unilamellar vesicles-aqueous solution is enclosed within vesicles
Liposomes Market Is Progressing Towards A Strong Growth By 2025
Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer. Liposomes can be divided into two categories on the basis of their size and the number of bilayers – unilamellar vesicles and multilamellar vesicles. Unilamellar vesicles-aqueous solution is enclosed within vesicles
Liposomes Market Research Report - Forecast 2017 – 2025
Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer. Liposomes can be divided into two categories on the basis of their size and the number of bilayers – unilamellar vesicles and multilamellar vesicles. Unilamellar vesicles-aqueous solution is enclosed within vesicles
Liposomes Market to be at Forefront by 2025
Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer. Liposomes can be divided into two categories on the basis of their size and the number of bilayers – unilamellar vesicles and multilamellar vesicles. Unilamellar vesicles-aqueous solution is enclosed within vesicles